Landscape analysis of m5C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinoma
Authors:
Open Access
- 22 August 2025
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 17 (1) , 1-17
Abstract
The 5-methylcytosine (m5C) post-transcriptional modification has been linked with the development and progression of a variety of cancers. However, its specific functions and their underlying mechanisms are poorly understood in hepatocellular carcinoma (HCC). The present study showed abnormally increased levels of m5C modifications in HCC that were positively correlated with both HCC progression and worse patient prognosis. Landscape profiling of metabolic characteristics showed dysregulation of pyrimidine metabolism mediated by DNA methyltransferases 1 (DNMT1), and cyclin-dependent kinase 1 (CDK1) was identified as a downstream effector upregulated by DNMT1 in an m5C-dependent manner, with CDK1 promoting pyrimidine metabolism. Knockdown of DNMT1 or CDK1 was found to reduce the proliferation, invasion, and migration of HCC cells in vitro. Moreover, pharmacological targeting of the DNMT1/CDK1/pyrimidine metabolism axis with specific inhibitors effectively suppressed tumor progression in HCC model mice. These findings demonstrated the landscape profiles of m5C-related metabolic features in HCC, showing stabilization of CDK1 mRNA by DNMT1-mediated m5C modification, resulting in the promotion of pyrimidine metabolism, a crucial feature of HCC progression. These insights highlight the therapeutic potential of targeting the DNMT1/CDK1/pyrimidine metabolism axis as a strategy for combating HCC.Keywords
This publication has 42 references indexed in Scilit:
- NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilizationCancer Letters, 2024
- The impact of epitranscriptomic modifications on liver diseaseTrends in Endocrinology & Metabolism, 2024
- Arginine reprograms metabolism in liver cancer via RBM39Cell, 2023
- NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistanceCell Metabolism, 2023
- Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinomaActa Pharmaceutica Sinica B, 2021
- Metabolic reprogramming and epigenetic modifications on the path to cancerProtein & Cell, 2021
- Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistanceCancer Letters, 2019
- Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinomaMolecular Oncology, 2017
- Dynamic RNA Modifications in Gene Expression RegulationCell, 2017
- RNA-Methylation-Dependent RNA Processing Controls the Speed of the Circadian ClockCell, 2013